BioInnovation Capital
Overview
-
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
| Vivace Therapeutics | Jun 2017 | Series B | Co-investor |
| GraphWear Technologies Inc. | Apr 2018 | Series A | Lead |
| Sentien Biotechnologies | Apr 2017 | Series A | Lead |
| Glycomine | Jun 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioInnovation Capital based?
BioInnovation Capital is headquartered in Cambridge, Massachusetts, United States.
When was BioInnovation Capital founded?
BioInnovation Capital was founded in 2009.
How many portfolio companies does BioInnovation Capital have?
BioInnovation Capital has 17 portfolio companies in Caplight's dataset.
What are some companies in BioInnovation Capital's portfolio?
Portfolio companies visible on Caplight include Nocion Therapeutics, Vivace Therapeutics, GraphWear Technologies Inc., Sentien Biotechnologies, Glycomine.
What was BioInnovation Capital's most recent investment shown here?
BioInnovation Capital's most recent investment in this portfolio sample was in Nocion Therapeutics in 2026.
What sectors does BioInnovation Capital focus on?
BioInnovation Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does BioInnovation Capital focus on?
BioInnovation Capital typically invests at the Early stage.
What is BioInnovation Capital's AUM?
BioInnovation Capital's assets under management are estimated between $250.0M and $500.0M.